{
    "title": "Pfizer sees $10 bln-$15 bln in potential revenue from mRNA vaccines by 2030",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11530135/Pfizer-sees-10-bln-15-bln-annual-mRNA-vaccine-revenue-2030.html",
    "date": "2022-12-12",
    "keywords": [
        "vaccine",
        "pfizer",
        "revenue",
        "company",
        "covid19",
        "demand",
        "treatment",
        "patent",
        "dec",
        "inc",
        "mrna",
        "portfolio",
        "hit",
        "topline",
        "decline",
        "york",
        "afternoon",
        "trade",
        "stock",
        "companys",
        "year",
        "level",
        "paxlovid",
        "forecast",
        "loss",
        "bigselling",
        "cancer",
        "ibrance",
        "drug",
        "officer",
        "hwang",
        "investor",
        "presentation",
        "pipeline",
        "manufacturing",
        "capacity",
        "comirnaty",
        "partner",
        "biontech",
        "se",
        "breakdown",
        "respiratory",
        "virus",
        "rsv",
        "candidate",
        "reporting",
        "bhanvi",
        "satija",
        "bengaluru",
        "michael",
        "erman",
        "jersey",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}